Vapotherm Inc. (VAPO)

10.01
NYSE : Health Technology
Prev Close 9.54
Day Low/High 9.42 / 10.31
52 Wk Low/High 8.30 / 24.63
Avg Volume 205.30K
Exchange NYSE
Shares Outstanding 20.60M
Market Cap 196.57M
EPS -14.70
Div & Yield N.A. (N.A)

Latest News

Vapotherm Becomes Oversold (VAPO)

Vapotherm Becomes Oversold (VAPO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Vapotherm Announces Proposed Public Offering Of Common Stock

Vapotherm Announces Proposed Public Offering Of Common Stock

Vapotherm, Inc. (NYSE: VAPO) ("Vapotherm"), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory...

Vapotherm Reports Second Quarter 2019 Financial Results

Vapotherm Reports Second Quarter 2019 Financial Results

Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, today...

Vapotherm To Report Second Quarter 2019 Financial Results

Vapotherm To Report Second Quarter 2019 Financial Results

Vapotherm, Inc. (NYSE: VAPO) ("Vapotherm"), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory...

Vapotherm To Present At The William Blair 39th Annual Growth Stock Conference

Vapotherm To Present At The William Blair 39th Annual Growth Stock Conference

Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, today...

Vapotherm To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference

Vapotherm To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference

Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, today...

Vapotherm Reports First Quarter 2019 Financial Results

Vapotherm Reports First Quarter 2019 Financial Results

Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, today...

Vapotherm To Report First Quarter 2019 Financial Results

Vapotherm To Report First Quarter 2019 Financial Results

Vapotherm, Inc. (NYSE: VAPO) ("Vapotherm"), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory...

Emergency Department Subgroup Study Showed Hi-VNI® Technology Had Similar Outcomes To Non-invasive Positive Pressure Ventilation In Management Of Respiratory Distress Among Acute Decompensated Heart Failure Patients

Emergency Department Subgroup Study Showed Hi-VNI® Technology Had Similar Outcomes To Non-invasive Positive Pressure Ventilation In Management Of Respiratory Distress Among Acute Decompensated Heart Failure Patients

Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology, today announced that a paper published in the American Journal of Emergency Medicine, titled "HVNI vs...

Vapotherm Reports Fourth Quarter And Fiscal Year 2018 Financial Results

Vapotherm Reports Fourth Quarter And Fiscal Year 2018 Financial Results

Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, announced...

Vapotherm® Releases Next Generation Of Capital Unit: Precision Flow Hi-VNI™ System

Vapotherm® Releases Next Generation Of Capital Unit: Precision Flow Hi-VNI™ System

Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI ® Technology products that are used to treat patients of all ages suffering from respiratory distress, today...

Vapotherm To Be Added To The Russell 2000®, 3000® And Microcap® Indexes

Vapotherm To Be Added To The Russell 2000®, 3000® And Microcap® Indexes

Vapotherm, Inc. (NYSE: VAPO) announced today that it has been added to the Russell 2000 ® , Russell 3000 ® and Russell Microcap ® Indexes, effective after market close on December 21, 2018, as part of Russell's quarterly addition of companies with recent...

Clinical Study Shows Vapotherm's New IntellO2™ Module For Precision Flow® System Significantly Improves Maintenance Of Premature Neonates In Target Oxygenation Range

Clinical Study Shows Vapotherm's New IntellO2™ Module For Precision Flow® System Significantly Improves Maintenance Of Premature Neonates In Target Oxygenation Range

Vapotherm, Inc. today announced the publication of a key prospective, multi-center, controlled, order-randomized crossover trial.

Vapotherm Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares

Vapotherm Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares

Vapotherm, Inc. (NYSE: VAPO) ("Vapotherm"), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI ® Technology products that are used to treat patients of all ages suffering from respiratory...

Vapotherm Announces Pricing Of Initial Public Offering

Vapotherm Announces Pricing Of Initial Public Offering

Vapotherm, Inc. (NYSE: VAPO) ("Vapotherm"), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI ® Technology products that are used to treat patients of all ages suffering from respiratory...